The Effects of Exenatide After Gastric Restriction
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe change in body weight in non-diabetic morbidly obese
patients after laparoscopic adjustable gastric banding (LAGB) with twice daily exenatide or
placebo injections.